Base modification detection (m6A, m5C, Ψ, inosine), poly(A) tail profiling, and full-length native transcript isoform analysis by Oxford Nanopore dRNA-seq on PromethION with RNA004 chemistry — no reverse transcription, no PCR amplification, no amplification bias
CD Genomics provides Nanopore Direct RNA Sequencing (dRNA-seq) on PromethION with RNA004 chemistry — the only commercially available RNA sequencing method that sequences native RNA molecules directly without reverse transcription or PCR amplification. Every read simultaneously delivers full-length transcript sequence, single-nucleotide RNA modification detection (m⁶A, m⁵C, Ψ, inosine), and poly(A) tail length measurement from the same unamplified native RNA molecule.
Every RNA sequencing method that relies on reverse transcription and PCR amplification introduces a fundamental trade-off: you gain throughput, but you lose the native RNA molecule. The cDNA copy is not the original — it carries the biases of reverse transcriptase (premature termination at structured regions, GC-dependent processivity, template-switching artifacts), the distortions of PCR duplication (amplification bias, loss of modification information), and the blind spots of fragmentation (loss of connectivity between distal transcript features). For transcriptome-wide RNA modification analysis, poly(A) tail profiling, and full-length native transcript characterization, these are not merely technical limitations — they are systematic information losses that no amount of computational correction can recover.
CD Genomics offers Nanopore Direct RNA Sequencing (dRNA-seq) — the only commercially available RNA sequencing method that sequences native RNA molecules directly. Using the Oxford Nanopore platform with RNA004 chemistry on PromethION and GridION instruments, our dRNA-seq service delivers full-length native transcript sequences, single-nucleotide RNA modification detection (m6A, m5C, pseudouridine Ψ, inosine, and 2′-O-methylation), poly(A) tail length measurements, and transcript isoform identification from the same unamplified RNA molecules. No reverse transcription bias. No PCR distortion. No fragmentation. The RNA molecule itself is the sequencing template.
At a glance:
The eukaryotic transcriptome is not a simple collection of linear sequences. Every mature mRNA carries a complex layer of regulatory information encoded in its base modifications, poly(A) tail length, splice isoform choice, and 5′/3′ untranslated region architecture — all of which are read and interpreted by the cellular machinery to determine transcript stability, localization, translation efficiency, and decay kinetics. These features are not independent; they function as an integrated regulatory code in which modification status can influence poly(A) tail length, splice isoform choice can determine modification sites, and both can vary dynamically across cell types, developmental stages, and disease states.
Short-read RNA-seq fragments this integrated code into disconnected pieces, then relies on computational reconstruction to approximate the original transcript structures. cDNA-based long-read methods (PacBio Iso-Seq, ONT cDNA-seq) preserve the full-length connectivity through reverse transcription and PCR, but the amplification step destroys all modification information and introduces RT-dependent biases that systematically underrepresent GC-rich transcripts, structured RNA regions, and low-abundance isoforms. Direct RNA sequencing eliminates both of these information barriers by sequencing the native RNA molecule directly, preserving the complete transcript structure, modification landscape, and poly(A) tail status of every captured molecule. This makes dRNA-seq the only method capable of simultaneously resolving what the transcript is (sequence and splice isoforms), what state it is in (base modifications), and how it is regulated (poly(A) tail length) from a single experiment.
Our Nanopore Direct RNA Sequencing service makes this integrated transcriptome-epitranscriptome analysis accessible as a commercial CRO service, with validated RNA004 chemistry protocols, modified-base-aware bioinformatics pipelines, and flexible project configurations matched to eukaryotic transcriptome complexity.
Nanopore Direct RNA Sequencing (dRNA-seq) is an Oxford Nanopore Technology-based method that sequences native RNA molecules directly without reverse transcription, PCR amplification, or chemical conversion. The method is fundamentally different from all other RNA-seq approaches: the RNA molecule itself acts as the sequencing template, and its native chemical state — including every base modification — is read directly through nanopore ionic current analysis.
The dRNA-seq library preparation process is designed to preserve the native RNA molecule while enabling nanopore translocation. Total or poly(A)-selected RNA is first assessed for integrity. An ONT-compatible 3′ adapter carrying the motor protein docking site is ligated directly to the RNA 3′ end (or, for total RNA, following polyadenylation). A reverse transcription step generates a complementary DNA (cDNA) strand that remains hybridized to the RNA, forming an RNA-cDNA duplex. This duplex is required for motor protein loading and processive translocation — the motor protein binds to the RNA strand and uses the cDNA as a guide strand to feed the RNA through the nanopore in a 3′-to-5′ direction. Importantly, the cDNA strand is never PCR-amplified; it serves only as a structural component for motor protein function, and the sequencing signal is generated from the native RNA strand, not the cDNA.
As the native RNA molecule passes through the nanopore, the ionic current is measured at kHz frequency. Each 5-nucleotide k-mer produces a characteristic current level. Modified bases — m6A, m5C, pseudouridine (Ψ), inosine, 2′-O-methylation — produce current signatures that deviate systematically from their unmodified counterparts, enabling identification at single-nucleotide resolution through comparative signal analysis against unmodified controls or through neural-network-based basecalling models trained to distinguish modified from unmodified bases. Simultaneously, the duration of the signal corresponding to the poly(A) tail region provides a direct measurement of poly(A) tail length at single-nucleotide resolution. All of this information — sequence, modifications, and poly(A) tail length — is derived from the same native RNA molecule in a single continuous translocation event.
Every base modification on the native RNA molecule is preserved and detectable through nanopore signal analysis. Unlike antibody-based methods (MeRIP-seq) that depend on enrichment efficiency and fragment length, or chemical methods (bisulfite sequencing for m5C) that require harsh treatment, dRNA-seq detects modifications directly from the ionic current signal. m6A at DRACH motifs, m5C in structured regions, pseudouridine at single-nucleotide resolution, and inosine from A-to-I editing sites are all identifiable from the same dataset without additional experimental steps.
Each dRNA-seq read is a complete native transcript molecule spanning from 5′ cap (captured through the RT primer) through the coding sequence and untranslated regions to the 3′ poly(A) tail. Splice isoform architecture is observed directly — there is no read fragmentation, no computational transcript assembly, and no isoform inference from single-exon fragments. The connectivity between exons, the distribution of splice sites, and the relationship between isoform choice and modification status are all captured at single-molecule resolution.
Poly(A) tail length is measured directly from the nanopore signal during RNA translocation, providing per-read poly(A) tail length estimates at single-nucleotide resolution. This enables transcript-resolved poly(A) tail analysis — correlating tail length with specific transcript isoforms, modification patterns, and expression levels on individual RNA molecules — that is not possible with bulk poly(A) tail assays or indirect estimation from short-read data.
Our dRNA-seq service delivers transcriptome sequence, modification profiles, poly(A) tail measurements, and isoform structures from one library preparation and sequencing run. Researchers receive integrated datasets that would otherwise require separate RNA-seq, MeRIP-seq, poly(A) tail assay, and isoform sequencing projects — reducing total cost, sample material requirements, and project coordination complexity. For expression-focused projects requiring higher throughput, our Full-Length Transcriptome Profiling and Nanopore Full-Length cDNA Sequencing provide complementary high-yield options.
We have validated and optimized the ONT RNA004 direct RNA sequencing kit on both PromethION and GridION platforms, with established protocols for poly(A)-selected RNA, total RNA, and low-input samples. Our direct RNA sequencing yields are benchmarked against published performance metrics, and we provide project-specific feasibility assessments for challenging sample types.
Our bioinformatics pipeline supports both focused modification analysis on specific transcripts of interest and transcriptome-wide discovery of modification sites, isoform structures, and poly(A) tail distributions. Standard basecalling with modified-base-aware models (Dorado v5+) provides initial modification probabilities, with advanced analysis options including comparative modification calling against matched unmodified controls, single-molecule modification heterogeneity analysis, and integrated poly(A) tail-modification-isoform correlation analysis.
We provide comprehensive project support including RNA extraction and QC guidance optimized for dRNA-seq, library preparation with RNA004 chemistry, PromethION or GridION sequencing with real-time monitoring, modified-base-aware bioinformatics with multi-modality data integration, and custom visualization for manuscript preparation. Our project scientists offer method selection guidance for researchers comparing dRNA-seq with cDNA-based or short-read approaches.
The table below provides a direct comparison of Nanopore Direct RNA Sequencing against the three other major RNA-seq approaches across all relevant technical dimensions, enabling researchers to evaluate which method best matches their experimental requirements.
| Feature | Nanopore Direct RNA Sequencing | ONT Direct cDNA Sequencing | PacBio Iso-Seq (PCR-cDNA) | Short-Read RNA-seq (Illumina) |
| Sequencing template | Native RNA (original molecule) | cDNA (reverse transcribed) | PCR-amplified cDNA | PCR-amplified cDNA fragments |
| Native base modifications preserved | ✓ Direct detection from native RNA | ✘ Lost during RT | ✘ Lost during RT-PCR | ✘ Lost during RT-PCR + fragmentation |
| Poly(A) tail measurement | ✓ Single-nucleotide resolution from raw signal | ✘ Not measurable from cDNA | ✘ Not measurable from PCR-cDNA | ✘ Requires separate 3′-seq assay |
| Read length | 500–2,500 nt (native RNA length; limited by RNA integrity and motor protein processivity) | 500–5,000+ nt (cDNA length; RT-dependent) | 1,000–10,000+ nt (PCR-cDNA, size-selected) | 50–300 bp (fragmented) |
| RT/PCR bias | None — no RT or PCR in sequencing pathway | RT bias (premature termination at structured regions, GC-dependent errors) | RT + PCR bias (amplification skew, GC bias, chimera formation) | RT + PCR + fragmentation bias (ligation, PCR duplication, GC-dependent amplification) |
| Throughput per flow cell | Low–Moderate (5–20 million reads on PromethION RNA004) | High (50–100+ million reads) | High (2–60 million reads per SMRT Cell with Kinnex) | Very high (100–500+ million reads per lane) |
| Base modification detection sensitivity | Single-nucleotide (requires coverage depth or comparative analysis) | Not applicable | Not applicable | Requires separate assay (MeRIP-seq, BS-seq, etc.) |
| 5′ to 3′ transcript coverage | Full-length native reads (3′ bias: RT primer at 3′ end increases 3′ coverage) | Full-length cDNA reads (some 5′ bias from RT drop-off) | Full-length PCR-cDNA (5′ and 3′ bias from template-switching) | 3′-biased (poly(A) selection + fragmentation) |
| Single-molecule information | Per-read sequence + modifications + poly(A) tail linked on each molecule | Per-read sequence only (no modification or poly(A) data) | Per-read sequence only (HiFi consensus, not single-molecule) | Not single-molecule (ensemble averages from fragment coverage) |
| RNA input requirement | 500 ng–5 μg poly(A)+ RNA (higher input required than cDNA methods) | 100 ng–1 μg total RNA | 100 ng–1 μg total RNA | 10–500 ng total RNA |
| Best suited for | RNA modification mapping, poly(A) tail analysis, native isoform validation, multi-modality transcriptome characterization | High-throughput full-length isoform discovery and quantification | High-accuracy full-length isoform sequencing, fusion transcript detection, de novo transcript annotation | High-throughput gene expression quantification, differential expression, small RNA analysis |
Beyond established applications in epitranscriptomics and isoform discovery, Nanopore direct RNA sequencing is increasingly deployed in clinical and translational settings — including rapid pathogen identification and antimicrobial resistance profiling directly from clinical samples, liquid biopsy-based detection of tumor-specific RNA modifications and fusion transcripts in circulating RNA, and real-time quality control of synthetic mRNA therapeutics where sequence fidelity, modification status, and poly(A) tail integrity are critical quality attributes that only native RNA sequencing can assess simultaneously from a single assay.
Our Nanopore Direct RNA Sequencing service is part of a broader RNA analysis ecosystem. The following complementary service modules support DRS projects across different research objectives — from targeted modification analysis to comprehensive transcriptome characterization.
Nanopore Full-Length cDNA Sequencing provides higher-throughput transcript isoform discovery for projects focused on transcript structure and expression quantification rather than modification analysis. While it does not preserve native RNA modification information, cDNA sequencing delivers 5–10 times more reads per flow cell, making it the preferred choice for deep isoform discovery, rare transcript detection, and transcriptome-wide expression profiling. We recommend cDNA sequencing as a complement to dRNA-seq for large-scale projects requiring both modification analysis and deep transcript coverage.
Full-Length Transcriptome Profiling provides an end-to-end solution for transcript discovery, isoform quantification, and functional annotation across any eukaryotic species. This module is optimized for de novo transcriptome projects in non-model organisms where a reference genome may not be available, and can be combined with dRNA-seq data for integrated isoform-modification analysis in species with limited genomic resources.
Oxford Nanopore Sequencing Data Analysis provides specialized bioinformatics support for direct RNA sequencing data, including modified-base-aware basecalling with Dorado v5+ and RNA-specific models, per-read modification probability estimation (m6A, m5C, Ψ, inosine), poly(A) tail length calling from raw signal data using tailfindr or similar tools, comparative modification analysis against unmodified control libraries, transcript isoform detection and quantification from native RNA reads, and integrated multi-modality report generation combining modification, isoform, poly(A) tail, and expression data.
High-quality RNA is the single most important determinant of dRNA-seq success. Poly(A)-selected RNA (recommended for mRNA-focused studies) or total RNA (with optional rRNA depletion) is assessed by microfluidic electrophoresis. RNA integrity (RIN ≥ 8 recommended for standard dRNA-seq), concentration, and purity are established. DNase treatment is performed to eliminate genomic DNA contamination, which competes with RNA for adapter ligation and reduces sequencing yield. For total RNA samples or bacterial RNA (which lacks poly(A) tails), a controlled polyadenylation step is added before adapter ligation.
The ONT RNA004 adapter, which includes the motor protein docking site and a reverse transcription primer binding site, is ligated to the RNA 3′ end. Reverse transcription generates a cDNA strand that remains hybridized to the RNA, forming the RNA-cDNA duplex required for processive motor protein loading. Importantly, this RT step uses only a short primer extension — it is not a full cDNA synthesis reaction and does not involve PCR amplification. The cDNA serves exclusively as a structural component for nanopore translocation; the sequencing signal is derived from the native RNA strand.
Figure 1. Nanopore Direct RNA Sequencing workflow: from RNA extraction and quality assessment through RNA004 adapter ligation, reverse transcription, motor protein loading, and nanopore sequencing with simultaneous basecalling and modification detection.
The motor protein is loaded onto the RNA-cDNA duplex. Once loaded onto the PromethION or GridION flow cell, the motor protein processively unwinds the RNA-cDNA duplex and feeds the RNA strand through the nanopore in a 3′-to-5′ direction at approximately 70–100 nucleotides per second. As each nucleotide passes through the pore, it modulates the ionic current in a sequence- and modification-dependent manner. The current is measured at kHz frequency, generating a continuous signal trace that encodes the complete transcript information.
The ionic current signal is basecalled in real time using ONT Dorado with RNA-specific models that can distinguish modified bases from their unmodified counterparts. Simultaneously, the signal corresponding to the poly(A) tail region is analyzed for tail length estimation. The resulting data stream includes per-read nucleotide sequences, per-nucleotide modification probability scores, poly(A) tail length estimates, and per-read quality metrics — all derived from the same native RNA molecule during a single translocation event.
Basecalled reads are aligned to the reference transcriptome or genome using splice-aware aligners (minimap2 with splice parameters). Downstream analysis includes: isoform detection and quantification (bambu, LIQA, or Flair), modification calling through comparative analysis against unmodified controls or using neural-network-based modification probability models (m6A via m6Anet, DRUMMER, or TandemMod; pseudouridine via NanoPsi or U-to-C error profiling; inosine via inosine-preferring alignment features), poly(A) tail length estimation (tailfindr or nanopolish), and integrated multi-modality correlation analysis linking modification status with isoform choice and poly(A) tail length on individual RNA molecules.
| Analysis Feature | Standard Package | Advanced Package |
| Dorado v5+ super-accuracy basecalling with RNA-specific modified-base models | ✓ | ✓ |
| Read QC, filtering (read length, quality score), adapter trimming | ✓ | ✓ |
| Splice-aware alignment to reference transcriptome/genome (minimap2) | ✓ | ✓ |
| Full-length transcript isoform detection and quantification (bambu, LIQA, or Flair) | ✓ | ✓ |
| Poly(A) tail length estimation (tailfindr or custom signal analysis) | ✓ | ✓ |
| Single-nucleotide m6A modification calling (m6Anet, DRUMMER, TandemMod) | — | ✓ |
| Multi-modification detection: m5C, Ψ, inosine, 2′-O-methylation | — | ✓ |
| Comparative modification analysis vs unmodified control (IVT) libraries | — | ✓ |
| Single-molecule modification heterogeneity analysis and co-occurrence detection | — | ✓ |
| Integrated multi-modality report (modification status × isoform usage × poly(A) tail length) | — | ✓ |
| Category | Poly(A)-Selected RNA (Recommended) | Total RNA (with rRNA depletion) |
| Sample type | Eukaryotic total RNA (poly(A)+ subpopulation isolated); mammalian, plant, fungal, or viral | Total RNA (prokaryotic or eukaryotic) with species-matched rRNA depletion; includes non-coding RNA fraction |
| Minimum input | 500 ng–5 μg (poly(A)+ RNA after selection) | 2–10 μg total RNA (yield depends on rRNA depletion efficiency) |
| RNA integrity | RIN ≥ 8 recommended (RIN ≥ 7 minimum); degraded RNA assessed case-by-case | RIN ≥ 7 recommended (prokaryotic RIN equivalents) |
| Recommended depth | 5–20 million reads per sample (PromethION flow cell, RNA004 chemistry) | 5–15 million reads per sample (lower mRNA proportion reduces useful yield) |
| Poly(A) selection | Included in standard workflow (oligo-dT bead capture) | Not applicable (total RNA workflow uses polyadenylation) |
| Modification detection | ✓ Endogenous modifications preserved; matched unmodified (IVT) control recommended for optimal sensitivity | ✓ Same as poly(A) workflow; rRNA modifications can also be profiled after depletion validation |
| Shipping | Overnight on dry ice (RNA or tissue); RNA in RNase-free water or storage buffer; see sample submission guidelines | |
Validated RNA004 direct RNA sequencing on PromethION and GridION
We have established and optimized the ONT RNA004 direct RNA sequencing kit across multiple PromethION and GridION instruments, with validated protocols for poly(A)-selected RNA from diverse eukaryotic species (human, mouse, plant, yeast, fungal), total RNA with rRNA depletion, and low-input samples. Our direct RNA yields are benchmarked against published performance data, and we provide detailed feasibility assessments for challenging sample types including clinical biopsies and laser-capture microdissected tissue.
Multi-modality data delivery from a single service
Unlike providers who deliver only transcript sequences, our dRNA-seq service is designed from the ground up as an integrated multi-modality analysis. Every project receives transcript isoform annotations with quantification, per-nucleotide modification probability tracks for multiple modification types, poly(A) tail length distributions per transcript, and integrated correlation analysis linking these data layers. Researchers receive a unified dataset rather than separate files from disconnected analyses.
Flexible analysis depth matched to your biological question
Not every project requires the same depth of analysis. Our Standard package provides comprehensive basecalling, alignment, isoform quantification, and poly(A) tail analysis suitable for most transcriptome characterization projects. The Advanced package adds single-nucleotide modification calling (m6A, m5C, Ψ, inosine), comparative analysis against unmodified controls, single-molecule modification heterogeneity assessment, and integrated multi-modality correlation analysis — providing the depth needed for epitranscriptomics-focused studies without over-engineering simpler projects.
Integrated service ecosystem for multi-platform RNA analysis
Our Nanopore Direct RNA Sequencing service does not operate in isolation. We offer complementary Nanopore Full-Length cDNA Sequencing for high-throughput isoform discovery, PacBio RNA Sequencing for HiFi-accuracy isoform validation, and Long-Read Sequencing of RNA Methylation for integrated epitranscriptome analysis across platforms. This multi-platform capability allows our project scientists to recommend the optimal combination of approaches for complex projects.
Proven track record in direct RNA sequencing across diverse applications
Our direct RNA sequencing service has supported published research across eukaryotic transcriptome characterization, RNA modification mapping in cancer biology, viral RNA genome analysis, and plant stress response epitranscriptomics. Our team's expertise spans from experimental design through bioinformatics interpretation, providing comprehensive support for researchers at every stage of their direct RNA sequencing project.
Wu Y, Shao W, Yan M, et al. Transfer learning enables identification of multiple types of RNA modifications using nanopore direct RNA sequencing. Nature Communications. 2024;15:4049. (CC BY 4.0)
Existing computational methods for detecting RNA modifications from nanopore direct RNA sequencing data are predominantly trained to recognize a single modification type (typically m6A) and require large, modification-specific training datasets. This single-modification paradigm limits the utility of DRS data, because a single dRNA-seq experiment simultaneously captures signal from all modification types present on the native RNA. The authors developed TandemMod, a transfer learning-based deep learning framework capable of identifying multiple RNA modification types (m6A, m5C, m7G, pseudouridine Ψ, and inosine) from a single nanopore DRS dataset, using an in vitro epitranscriptome (IVET) training strategy and transfer learning to reduce the training data requirements for each modification type.
In vitro epitranscriptome (IVET) datasets were generated from cDNA libraries containing thousands of transcripts with controlled modification labels for five modification types. These IVET libraries were sequenced by ONT direct RNA sequencing to produce training data with known modification ground truth. The TandemMod architecture uses a 1D convolutional neural network (CNN) with bidirectional long short-term memory (Bi-LSTM) layers and an attention mechanism, trained on the IVET datasets. Transfer learning was then applied to extend the model to each additional modification type, requiring substantially less training data than de novo model training. The framework was validated on human cell line DRS data and applied to rice transcriptome data from plants grown under normal and high-salt stress conditions.
Fig. 2. TandemMod model and performance evaluation on published datasets. From Wu Y, Shao W, Yan M, et al. (2024, Nature Communications, CC BY 4.0).
This study provides a validated computational framework for extracting multi-modification information from standard Nanopore direct RNA sequencing data, demonstrating that the information content of a single dRNA-seq experiment extends far beyond single-modification profiling. The TandemMod transfer learning approach establishes that comprehensive epitranscriptome characterization — covering m6A, m5C, m7G, Ψ, and inosine — is achievable from standard DRS libraries without modification-specific sample preparation. These findings validate our dRNA-seq service design: by deploying modified-base-aware basecalling and multi-modification analysis pipelines, we ensure that our dRNA-seq service delivers the full multi-modality information content that direct RNA sequencing is uniquely capable of providing.
CD Genomics provides free project consultation to help determine the optimal RNA sequencing strategy for your specific research questions. Contact our scientists to discuss your project requirements.
Beyond the featured case study above, our Nanopore Direct RNA Sequencing service has supported a broad range of research projects — from neurodegenerative disease epitranscriptomics and plant RNA modification biology to synthetic RNA quality control and host-pathogen transcriptome analysis. Selected examples are highlighted below.
Researchers at Genentech employed Nanopore DRS to profile full-length transcript isoforms, m6A modifications, and poly(A) tail lengths across iPSC-derived human brain cell types (neurons, astrocytes, microglia, oligodendrocytes) and post-mortem Alzheimer's disease (AD) brain tissues. DRS was integrated with Ribo-seq and quantitative mass spectrometry to build a multi-omic atlas connecting mRNA abundance, m6A status, translational engagement, and protein abundance from the same biological samples. The study demonstrated that m6A profiles from DRS could distinguish early-stage (Braak I–III) from late-stage (Braak IV–VI) Alzheimer's pathology, with global hypomethylation observed in late-stage samples — establishing DRS-based epitranscriptomic profiling as a powerful approach for neurodegenerative disease research. Additionally, DRS identified 3.2× more annotated genes and 3.0× more transcript isoforms compared to cDNA-PCR sequencing, with 48 novel ORFs validated by mass spectrometry that were invisible to cDNA-based methods.
Reference: Byrne A, Hoover J, Lund J, et al. Direct RNA Sequencing reveals epitranscriptomic regulation of brain cells and Alzheimer's Disease pathology. bioRxiv. 2026. DOI: 10.64898/2026.05.18.724443.
In a study published in PLOS Genetics, Sun et al. used Nanopore DRS to profile m6A methylation changes genome-wide in Arabidopsis thaliana fio1 loss-of-function mutants. The DRS analysis revealed that FIONA1 (FIO1), a methyltransferase homologous to human METTL16, is responsible for m6A methylation of the 3′UTR of FLOWERING LOCUS C (FLC) mRNA. This methylation mark stabilises FLC transcripts; its loss in fio1 mutants causes FLC mRNA destabilisation and rapid degradation, leading to early flowering and pleiotropic developmental phenotypes. The study validated DRS as a powerful tool for plant epitranscriptomics and demonstrated that single-nucleotide m6A detection from native RNA can resolve methylation-function relationships that are inaccessible to antibody-based methods.
Reference: Sun B, Bhati KK, Song P, et al. FIONA1-mediated methylation of the 3′UTR of FLC affects FLC transcript levels and flowering in Arabidopsis. PLOS Genetics. 2022;18(9):e1010386. DOI: 10.1371/journal.pgen.1010386.
Our DRS service was engaged by Sanofi Pasteur for quality-control-grade sequencing of synthetic RNA and DNA constructs. The project involved DRS-based characterisation of 2 kb purified in vitro transcribed (IVT) RNA and 2 kb purified fragment DNA, with the objective of verifying synthetic sequence accuracy and detecting any unintended base modifications introduced during in vitro transcription. DRS successfully confirmed the designed sequence with single-nucleotide resolution, identified the expected modification profiles on the IVT RNA, and provided full-length native transcript coverage without the amplification bias that would be introduced by cDNA-based sequencing. This project demonstrated the utility of DRS as a QC tool for synthetic biology and RNA therapeutic development, where sequence fidelity and modification status are critical quality attributes.
In a collaborative project with the University of Pittsburgh School of Medicine, our DRS service was applied to 12 virus-infected cell samples to simultaneously profile host RNA modification changes and transcript alternative splicing dynamics in response to viral infection. DRS enabled integrated detection of infection-induced m6A re-distribution across the host transcriptome, condition-specific alternative splicing events (exon skipping, intron retention, alternative 5′/3′ splice site usage), and poly(A) tail length alterations — all from the same native RNA sequencing data. The single-molecule resolution provided by DRS was critical for linking modification status with specific transcript isoforms on individual RNA molecules, revealing epitranscriptomic regulatory mechanisms in host-pathogen interactions that would be fragmented or invisible in cDNA-based or short-read RNA-seq data.
Direct RNA Sequencing (dRNA-seq) sequences the native RNA molecule directly without reverse transcription or PCR amplification, preserving every base modification (m6A, m5C, Ψ, inosine) and enabling poly(A) tail length measurement. cDNA-based methods (including ONT cDNA-seq and PacBio Iso-Seq) require RT and PCR, which destroy modification information and introduce amplification biases. The trade-off is throughput: dRNA-seq currently yields 5–20 million reads per PromethION flow cell, while cDNA methods yield 50–100+ million reads. The choice depends on whether modification and poly(A) tail information is required for your biological question.
Our standard analysis pipeline detects m6A at single-nucleotide resolution across DRACH motifs using modified-base-aware Dorado models and m6Anet/DRUMMER validation. Advanced analysis additionally profiles m5C, pseudouridine (Ψ), inosine (A-to-I editing), and 2′-O-methylation using comparative signal analysis against matched unmodified (IVT) control libraries or neural-network-based multi-modification frameworks. For optimal sensitivity across all modification types, we recommend including matched unmodified control libraries generated from the same RNA sample by in vitro transcription.
The standard dRNA-seq protocol requires 500 ng–5 μg of poly(A)-selected RNA (RIN ≥ 8 recommended, RIN ≥ 7 minimum). For total RNA workflows (with rRNA depletion), 2–10 μg of total RNA is required. RNA integrity is the most critical factor — degraded RNA produces short reads that reduce mappable yield and compromise modification detection sensitivity. For samples with limited RNA availability (clinical biopsies, LCM-captured tissue) or degraded RNA, please consult our project scientists for feasibility assessment; we have successfully processed challenging samples with optimized low-input protocols.
Yes — this is one of the unique capabilities of Nanopore Direct RNA Sequencing. Every single sequenced read provides three data streams simultaneously: the transcript sequence (including splice isoform structure), modification probability scores at each nucleotide position, and the poly(A) tail length derived from the 3′-end signal. Our integrated analysis pipeline delivers per-read modification probabilities and per-read poly(A) tail length estimates, enabling direct correlation between modification status and tail length on individual RNA molecules — analysis that is impossible with any other RNA-seq method.
The ONT RNA004 kit introduces an optimized motor protein and adapter system specifically designed for native RNA sequencing, replacing the earlier R9.4.1 chemistry. Key improvements include: higher sequencing yield (3–5 times more reads per flow cell compared to R9.4.1), improved motor protein processivity enabling longer read lengths, more consistent translocation speed for improved basecalling accuracy, and better compatibility with a wider range of RNA input amounts. We deploy RNA004 chemistry as our standard dRNA-seq workflow on PromethION and GridION instruments.
1. Basecalled FASTQ files with per-read modification probability tags (MM/ML SAM tags) from Dorado v5+ RNA-specific modified-base models, ready for downstream analysis and public data deposition
2. Genome-aligned BAM files with splice-aware alignments, modification probability tracks, and read-level poly(A) tail length annotations, suitable for visualization in IGV or UCSC Genome Browser
3. Transcript isoform annotation and quantification report including full-length isoform structures, isoform-level expression matrices, splice junction analysis, and comparison with reference annotations
4. RNA modification analysis report with per-nucleotide modification probability tracks (bigWig), significant modification sites with genomic coordinates and confidence scores, condition-specific differential modification analysis, and per-read modification heterogeneity visualization
5. Poly(A) tail length analysis report with per-transcript poly(A) tail length distributions, transcript-resolved tail length summaries, and integrated correlation analysis linking modification status, poly(A) tail length, and isoform usage at single-molecule resolution
References
For research use only. Not for use in diagnostic procedures.